On March 29, the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) to treat anemia in adult patients who had chronic kidney disease…
A study published in JAMA Psychiatry has found that common methods of assessing mental or physical disorders may consistently underestimate the prevalence of mental…
On Dec. 18, the U.S. Food and Drug Administration (FDA) approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in…
A study published in JAMA Psychiatry has found that common methods of assessing mental or physical disorders may consistently underestimate the prevalence…
On Dec. 18, the U.S. Food and Drug Administration (FDA) approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for…